Market Overview - A-shares opened lower and fluctuated, with the North Stock 50 showing relative strength, while the ChiNext index fell below the 2000-point mark, and the Shanghai 50 and CSI 300 reached new lows in this adjustment cycle [1] - The number of declining stocks far exceeded those that rose, with trading volume continuing to increase moderately [1] Sector Performance - The agriculture, forestry, animal husbandry, and fishery, pharmaceutical and biological, real estate, and brain engineering sectors saw the largest gains, while sectors such as controlled nuclear fusion, consumer electronics, reducers, and humanoid robots experienced the largest declines [2] Agriculture, Forestry, Animal Husbandry, and Fishery Sector - The agriculture, forestry, animal husbandry, and fishery sector collectively strengthened, with the breeding industry leading the gains, and the sector index rising nearly 4% shortly after opening, surpassing the previous day's total trading volume within 15 minutes [3] - All stocks in this sector were in the green, with companies like Juxing Agriculture and Animal Husbandry hitting the daily limit within minutes of opening [3] - Sub-sectors such as pork, feed, seed, and dairy products also performed well, with companies like Guangming Meat Industry and Qiu Le Seed Industry showing strong upward momentum [4] - Recent policy developments include the Shanghai Municipal People's Congress reviewing the "Shanghai Grain Security Guarantee Regulations (Draft)" and Sichuan Province drafting measures to promote high-quality development in the livestock industry, which aim to support leading enterprises in the sector [4] - Analysts believe that the agriculture sector, as a typical essential consumer goods category, has stable demand and strong policy support, making it a potential safe haven for capital amid a complex external environment [4] Pharmaceutical Sector - The pharmaceutical sector continued to show strength, with the innovative drug segment leading the gains, and the sector index rising over 3%, reaching a 1.5-year high [5] - Companies like Ruizhi Pharmaceutical and Warner Pharmaceuticals saw their stocks hit the daily limit, while others like Huasen Pharmaceutical and Lianhua Technology also experienced significant gains [5] - Sub-sectors such as immunotherapy, chemical pharmaceuticals, generic drugs, and biological vaccines also saw strong increases, with multiple stocks hitting the daily limit [6] - The ASCO annual meeting, a major global oncology conference, is currently taking place, with over 70 research projects from Chinese scholars being presented, marking a new high [6] - The National Medical Products Administration recently approved 11 innovative drugs for market release, providing new treatment options for various cancers and major diseases [6] - Analysts suggest focusing on innovation-driven and internationalization strategies in the pharmaceutical sector, particularly in the innovative drug field, as market sentiment improves post-collection optimization [7]